Salesforce.com to B...
Health Care: Drugs
GTx Inc. (GTXI: NASDAQ)
$2.71 -0.08 | -2.87%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 63.74M | 58.18M | 40.22M | 95.51M |
| Receivables | 981.00K | 683.00K | 595.00K | 1.26M |
| Inventories | 161.00K | 171.00K | 116.00K | 92.00K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 76.85M | 60.36M | 50.68M | 100.02M |
| Property, Plant & Equipment, Gross | 9.20M | 9.18M | 9.78M | 9.05M |
| Accumulated Depreciation & Depletion | 8.11M | 7.14M | 6.49M | 5.07M |
| Property, Plant & Equipment, Net | 1.10M | 2.04M | 3.29M | 3.99M |
| Intangibles | 240.00K | 1.85M | 3.76M | 4.09M |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 4.00K |
| Total Non-Current Assets | 1.34M | 3.89M | 7.05M | 8.08M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 78.18M | 64.25M | 57.72M | 108.11M |
| Accounts Payable | 1.22M | 848.00K | 1.27M | 2.82M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 6.08M | 5.30M | 15.95M | 20.98M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 234.00K | 7.22M | 50.52M | 55.11M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 234.00K | 7.22M | 50.52M | 55.11M |
| Total Liabilities | 6.31M | 12.52M | 66.47M | 76.09M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 71.87M | 51.73M | -8.75M | 32.02M |
| Common Par | 63.00K | 52.00K | 36.00K | 36.00K |
| Additional Paid In Capital | 457.98M | 404.56M | 359.39M | 353.90M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -386.17M | -352.88M | -368.17M | -321.92M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 71.87M | 51.73M | -8.75M | 32.02M |
| Total Equity | 71.87M | 51.73M | -8.75M | 32.02M |
| Total Liabilities & Stock Equity | 78.18M | 64.25M | 57.72M | 108.11M |
| Total Common Shares Outstanding | 62.79M | 51.72M | 36.42M | 36.39M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 57.36M | 38.87M | 36.42M | 36.30M |
| Diluted Weighted Shares Outstanding | 57.36M | 38.87M | 36.42M | 36.30M |
| Number of Employees | 90 | 111 | 120 | 147 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with GTXI
- Portfolio NameUser Type
- UserCURRENT#1
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- ContributorStocks With Big Insider Buy...
- Contributor10 Cheap Biotech Stocks Tha...
- UserRimp's Stockpicks
- UserOwn
- ContributorUnder $5 Stocks That May Be...
- ContributorBarron's Insider Purchases ...
Latest GTXI Headlines from TheStreet
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 5 Stocks Insiders Love Right Now 03.15.12 | 01:03 pm
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- GTx Stock Gaps Down On Today's Open (GTXI) 02.21.12 | 08:02 am
- 5 Stocks With Big Insider Buying 07.01.11 | 02:07 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- GTx Inc. Stock Downgraded (GTXI) 05.11.11 | 06:05 am
- GTx Inc. Stock Upgraded (GTXI) 05.09.11 | 08:05 am
- Under $5 Stocks That May Be Headed Lower 08.09.10 | 06:08 am
Press Releases for GTXI
- GTx Announces Webcast Of Corporate Presentation At Jefferies 2012 Global Healthcare Conference - Business Wire 05.29.12 | 07:05 am
- GTx Announces Removal Of Full Clinical Hold By FDA For Capesaris® In Advanced Prostate Cancer - Business Wire 05.08.12 | 06:05 am
- GTx, Inc. To Host First Quarter 2012 Financial Results Conference Call And Webcast - Business Wire 04.25.12 | 07:04 am
- GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris® For Secondary Hormonal Therapy Of Advanced Prostate Cancer - Business Wire 04.04.12 | 06:04 am
- GTx Announces Webcast Of Corporate Presentation At The Cowen And Co. Annual Health Care Conference - Business Wire 03.02.12 | 07:03 am
- GTx Announces Webcast Of Corporate Presentation At The Citi 2012 Global Health Care Conference - Business Wire 02.24.12 | 07:02 am
- GTx Provides Corporate Update And Reports 2011 Financial Results - Business Wire 02.21.12 | 06:02 am
- GTx Announces Clinical Hold On Clinical Trials Evaluating Capesaris® For First And Second Line Treatments Of Advanced Prostate Cancer - Business Wire 02.21.12 | 06:02 am
- GTx, Inc. To Host Fourth Quarter And Full Year 2011 Financial Results Conference Call And Webcast - Business Wire 02.13.12 | 07:02 am
- GTx Announces Webcast Of Corporate Presentation At The Lazard Capital Markets Annual Healthcare Conference - Business Wire 11.10.11 | 07:11 am
Partner Headlines for GTXI
- Analyzing GTx, Inc.'s Vast Upside Potential - Seeking Alpha 03.26.12 | 09:03 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Calls Purchased on GTx, Inc. - Benzinga 06.20.11 | 01:06 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- GTx Up Nearly 26% (GTXI) - Benzinga 04.13.11 | 09:04 am
- 20 Stocks Under $3 With Significant Insider Buying - Seeking Alpha 03.14.11 | 09:03 am
- Insider Buys and Sells: Coca-Cola, Amazon - Seeking Alpha 11.09.10 | 09:11 am
- GTx Inc. Pops on Study Results (GTXI) - Benzinga 09.15.10 | 09:09 am
